[{"Assets_0_Q3_USD":"739110000.0","CIK":"1023024","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.55","EarningsPerShareBasic_3_Q3_USD":"-2.76","EarningsPerShareDiluted_1_Q3_USD":"-0.55","EarningsPerShareDiluted_3_Q3_USD":"-2.76","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"569805985.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"-26803000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"-9006000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"-44871000.0","NetIncomeLoss_1_Q3_USD":"-8600000.0","NetIncomeLoss_3_Q3_USD":"-43653000.0","OfficialName":"ANI Pharmaceuticals Inc.","PaymentsOfDividends_3_Q3_USD":"1218000.0","ProfitLoss_3_Q3_USD":"-43653000.0","RevenuesConverted_1_Q3_USD":"83821000.0","RevenuesConverted_3_Q3_USD":"222153000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"311825000.0","Ticker":"ANIP","TreasuryStockSharesConverted_0_Q3_shares":"145851.0","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"16303000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"16238000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"16303000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"16238000.0","filed":"20221109","footnote":null,"form":"10-Q","fp":"Q3","fy":"2022.0","name":"ANI PHARMACEUTICALS INC","period":"20220930","qtrs":"0","uom":"USD"}]